2021 ACMT/ASAM Addiction Toxicology Case Conferences

4.61 (18 votes)

The Live Event Scheduled for 02/05/2021 at 1:00 PM (EST) has been Cancelled

  • Register
    • Non-Member - Free!
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

2021 ACMT/ASAM Addiction Toxicology Case Conferences

Live & On-Demand Webinars

Overview

This free series of live and on-demand webinars occurs on the first Friday of the month and discusses addiction/toxicology cases in an interactive fashion featuring experts from addiction medicine, addiction psychiatry, and medical toxicology.

The American College of Medical Toxicology (ACMT) recurring "3rd Friday Addiction Toxicology Case Conference" series is co-hosted by the American Society of Addiction Medicine (ASAM). The co-hosted series is an interactive discussion of addiction toxicology cases and will feature ASAM and ACMT members, as well as guest experts. 

Live webinars occur on the first Friday of every month, register for the live Case Conference here. You can access on-demand recordings of previous Case Conferences in the contents tab. 

The target audience for this introductory level activity includes: all members of the care team. 

This activity addresses the following ACGME Competencies: Patient Care, Medical Based Knowledge, Practice Based Learning.

Please Note: CME is available for the ACMT webinars between April 2020 and January 8, 2021. Certificates of attendance are available for Case Conferences held after January 8, 2021.

Registration Rates

ASAM Learner TypeRate
ASAM Member$0
Non-Member$0
Associate Member$0
Resident Member*$0
Student Member*$0

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 08/16/2024

Instructions

  1. Click on the Contents tab to begin this activity.
  2. Click the dates in the contents menu to view the sessions and presentation slides.
  3. Click the button Claim Medical Credits in the box titled View Certificate of Completion. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Moderators: 
    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM (ACMT/ASAM Expert) 
    Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY 
    Gloria J. Baciewicz, MD, FASAM 
    Director, Addiction Psychiatry Program (called Strong Recovery Addiction Psychiatry Program); Medical Director, Adult Ambulatory Program for Strong Health; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY 
Friday, January 8, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Arianna Sampson Campbell, PA-C (Guest Expert)
    Director, Co-Principal Investigator, California Bridge, Placerville, CA

    Frank J. Edwards, MD, FACEP (Guest Expert)
    GME Research Director, Associate Designated Institutional Official, Arnot Health Graduate Medical Education, Arnot Ogden Medical Center, Elmira, NY

    Eric J. Hill, CADC-I (Guest Expert)
    Substance Use Navigator, Emergency Department, Marshall Medical Center, Placerville, CA

    Nicholas Nacca, MD (ACMT Expert)
    Assistant Professor Emergency Medicine, University of Rochester Medical Center, Rochester, NY

    Ross Sullivan, MD (ACMT/ASAM Expert)
    Director of Medical Toxicology, Upstate University Hospital; Director, Upstate Emergency Medicine Opioid Bridge Clinic; Medical Director, Helio Health, Syracuse, NY
Cases:
  1. A 27-year-old M presents to the ED with cellulitis from IVDU. He had relapsed with fentanyl and cocaine in April 2020 as a month Rx his pharmacy changed to delivering all medication early in the COVID-19 pandemic and his Rx was “stolen”. He’d gone without buprenorphine/naloxone for several days and, unable to contact his clinic, he’d used heroin/fentanyl then was, “just back at it....” Interested in getting back into treatment and restarting buprenorphine/naloxone as soon as possible.
  2. A 38-year-old M is interested in getting help for stimulant and opioid use but the inpatient program he’d wanted to enter is “holding admits due to a COVID19 outbreak,” and there is a two-week wait for either telemedicine or on-site evaluation at the county treatment program in a rural part of the state. After 3 days of trying to “detox at home,” he presents to the Emergency Department because, “I didn’t know what else to do.” Patient is in florid opioid withdrawal with rhinorrhea, tearing, yawns repeatedly, has vomiting and diarrhea and is extremely anxious and restless.
Friday, March 5, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Nancy Onisko, DO, FACEP (Guest Expert)
    Assistant Professor of Emergency Medicine, Faculty in Medical Toxicology, University of Texas Southwestern Medical Center; Co-Director, Perinatal Intervention Program, Parkland Hospital and Health System, Dallas, TX
    Neil S. Seligman, MD, MS (Guest Expert)
    Director, Labor & Delivery, Strong Memorial Hospital; Associate Professor, Division of Maternal- Fetal Medicine, University of Rochester Medical Center, Rochester, NY
    Tricia Wright, MD, MS, FACOG, DFASAM (ASAM Expert)
    Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of California San Francisco, San Francisco, CA
Cases:
  1. A 29-year-old G2P10012 female delivers a 7 lb 2.8 oz baby boy at 38 3/7 weeks. Apgars at 1 min and 5 min 7 and 8. At 33 hours the newborn is noticed to be “jittery, have increased tone, very spitty” and has 6 x stools and 7 x emesis. Scoring 11 and 9 for NAS and transferred the following day to a tertiary care center. Mother has been diagnosed with BPAD and was taking a variety of medications, including venlafaxine, throughout pregnancy. No urine or meconium testing done. Toxicology consulted as patient’s NAS have increased to >15 on day 3 despite use of clonidine 1 mcg/kg/6 hours and phenobarbital 2.5 mg/kg/day. Is this SNRI withdrawal/discontinuation? How do you proceed?
  2. A 27-year-old female with a long history of polydrug dependence, including opioids and stimulants, had been staying in a local YWCA-associated program for women in recovery. She was prescribed 8/2 mg buprenorphine/naloxone SL TID and had been taking that for 6 months. She was also prescribed gabapentin 800 mg PO TID (though reported taking extra at times). Other meds include clonidine (taken intermittently). After delivery, her baby is scoring much higher than anticipated, despite treatment for NAS, and the NICU consults Toxicology for evaluation regarding possible gabapentin and other substance withdrawal as well.
Friday, April 2, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Erik Gunderson, MD, DFASAM (ASAM Expert)
    Director, Center for Wellness and Change; Associate Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA
    Barry K. Logan, PhD, F-ABFT (Guest Expert)
    Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA
    Michael Weaver, MD, DFASAM (ASAM Expert)
    Medical Director, Center for Neurobehavioral Research on Addiction; Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX
Cases:
  1. A 31-year-old M with opioid use disorder and extensive history of synthetic cannabinoid dependence re-engages with an outpatient treatment program during COVID-19. He reports, “trouble restarting the Suboxone because of fentanyl,” and that he cannot stop using K2 because he has withdrawal when he does.
  2. A 25-year-old M is brought to the ED from jail after turning himself in. His significant other had encouraged him to do so for warrant, partly because he needed to stop using K2 and “sort everything out for a while.” During a search, several balloons containing a substance are discovered and two are recovered by the guards; however, one is grabbed and swallowed by the individual. He is brought to the ED and, shortly after arrival, has a seizure. His UDS is positive for fentanyl and negative for everything else.
Friday, May 7, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Alexandra M. Amaducci, DO (ACMT Expert)
    Medical Toxicology Fellow, Emergency Medicine Physician, Lehigh Valley Health Network, Bethlehem, PA
    John A. Hopper, MD, DFASAM, FAAP, FACP (ASAM Expert)
    Recovery Medicine Physician, Integrated Health Associates, Ann Arbor, MI Clinical Professor, Wayne State University School of Medicine, Detroit, MI Clinical Professor, Central Michigan University, Mount Pleasant, MI
    Daniel J. Sessions, MD (ACMT Expert)
    Medical Toxicologist, Emergency Care Consultants; Minnesota Poison Control Systems, Minneapolis, MN
Cases:
  1. A 24-year-old M reports hearing loss and tinnitus after he is awoken from overdose from EMS-administered naloxone after using a “Research Chemical” he’d ordered from the Internet called MT-45.
  2. A 28-year-old M self-proclaimed ‘psychonaut’ has been using a ‘nootropic’ called tianeptine but reports, “it’s gotten out of hand.” He describes difficulty in stopping use and using in increasing amounts. When he tries to stop, he has diarrhea, chills and “shock-like feelings like static electricity but continuous.”
Friday, June 4, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    JoAn Laes, MD, FACMT, FASAM (ACMT/ASAM Expert)
    Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN
    Barry K. Logan, PhD, F-ABFT (Guest Expert)
    Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA
    Lewis Nelson, MD, FACMT, FASAM (ACMT/ASAM Expert)
    Professor and Chair, Department of Emergency Medicine; Chief, Division of Medical Toxicology, Rutgers New Jersey Medical School, Newark, NJ
    Rachel Wightman, MD (ACMT Expert)
    Director, Medical Toxicology Education; Assistant Professor, Department of Emergency Medicine, Warren Alpert Medical School, Brown University, Providence, RI
Cases:
  1. "I used to be able to take an 8 mg ‘Sub’ 24 hours after stopping. Now here I am in the ED!” A 24-year-old with panic, tearing, nausea, vomiting, and repeated yawning just can’t stop moving around after trying to restart buprenorphine/naloxone after 2 weeks of heavy heroin use.
  2. 3 doses of 4 mg IN naloxone in rapid succession in a patient down from presumed heroin OD is in severe withdrawal 20 minutes after rolls into the ED.
  3. 3 doses of 4 mg IN naloxone in rapid succession in a patient down from presumed heroin OD is in severe withdrawal 20 minutes after rolls into the ED.
Friday, July 2, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Richard S. Dent, MD (Guest Expert)
    Medical Director, Chemical Dependency Services, Rochester Regional Health; Clinical Senior Instructor (Voluntary), Department of Family Medicine, University of Rochester Medical Center, Rochester, NY
    Robert K. Horowitz, MD (Guest Expert)
    Chief, Division of Palliative Care; Georgia and Thomas Gosnell Distinguished Professor in Palliative Care, University of Rochester Medical Center, Rochester, NY
    Thomas St. John, CRPA-P (Guest Expert)
    Peer Advocate, Delphi Rise, Rochester, NY
    Ross Sullivan, MD (ACMT/ASAM Expert)
    Director, Medical Toxicology Education; Assistant Professor, Department of Emergency Medicine, Warren Alpert Medical School, Brown University, Providence, RI
Cases:
  1. Coordinating treatment for a 57-year-old patient with head and neck cancer, and severe substance use disorder.
  2. 3 doses of 4 mg IN naloxone in rapid succession in a patient down from presumed heroin OD is in severe withdrawal 20 minutes after rolls into the ED.
  3. Balancing harm reduction strategies for a patient with severe opioid and stimulant use disorder who repeatedly requests restarting buprenorphine films from a detox setting.
Friday, August 6, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Joseph D’Orazio, MD, FAAEM, FACMT (ACMT Expert)
    Associate Professor of Clinical Emergency Medicine; Director, Division of Medical Toxicology, Department of Emergency Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
    Jeanmarie Perrone, MD, FACMT (ACMT Expert)
    Professor, Department of Emergency Medicine; Director, Division of Medical Toxicology and Addiction Medicine Initiatives, Perelman School of Medicine; Director, Penn Center for Addiction Medicine and Policy, University of Pennsylvania, Philadelphia, PA.
    Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM (ASAM Expert)
    Chief of Medical Services, New York State Office of Addiction Services and Supports, Albany, NY. Mayra Rodriguez Beltran, PA-C (Guest Expert)
    Director of Medical Services, Huther Doyle, Rochester, NY.
    Edwin A. Salsitz, MD, DFASAM (ASAM Expert)
    Associate Clinical Professor of Psychiatry, Icahn School of Medicine, Mount Sinai Beth Israel, New York, NY.
Cases:
  1. Xylazine in the illicit drug supply and a cluster of overdose deaths.
  2. Vaccine hesitancy in substance use disorder treatment.

Friday, September 3, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
JoAn Laes, MD, FACMT, FASAM (ACMT/ASAM Expert)
Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN
Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM (ASAM Expert)
Chief of Medical Services, New York State Office of Addiction Services and Supports, Albany, NY.
Mayra Rodriguez Beltran, PA-C (Guest Expert)
Director of Medical Services, Huther Doyle, Rochester, NY.
Cases:
  1. A 30-year-old male wants to stop drinking but not completely. Looking at the use of PRN naltrexone tablets before going out to events with alcohol.
  2. Home dosing of phenobarbital, different models of 'ambulatory detox' that incorporate telemedicine visits, and when to add anti-craving medications.
Friday, October 1, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Speakers: 
    Timothy Carnes, MD (ASAM Expert)
    Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY.
    Joseph Carpenter, MD (ACMT Expert)
    Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
    Zachary Illg, DO (Guest Expert)
    Medical Toxicology Fellow, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA. Alaina Steck, MD (ACMT Expert)
    Associate Professor, Department of Emergency Medicine, Emory University, Medical Director, Grady Medication-Assisted Opioid Treatment (MAOT) Clinic, Assistant Medical Director, Georgia Poison Center, Atlanta, GA.
Cases:
  1. 23-year-old male with use of 7 grams a day of phenibut with anxiety, tremors, and sweats with any attempts to taper. Looking for a withdrawal protocol at a medically supervised detoxification level of care for 7-10 days.
  2. Patient with use of kratom, alcohol, and sedatives (intermittent benzodiazepines) has a seizure after brief relapse with alcohol about a week after leaving detox for alcohol and sedative use. Kratom use was not addressed during detox.

Please Note: CME is available for the ACMT webinars between April 2020 and January 8, 2021. Certificates of attendance are available for Case Conferences held after January 8, 2021.

CME, CE, CEU and Other Credit Types

ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity does not include any credits.  Learners do have the ability to download a certificate of completion.

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Key:

Complete
Failed
Available
Locked
January 8, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session - January 8, 2021
Open to view video.
Open to view video. This video is approximately 65 minutes and was recorded on 01/08/2021.
View Presentation Slides - January 8, 2021
Open to download resource.
Open to download resource.
Complete Evaluation - January 8, 2021
17 Questions
17 Questions Scroll down on all questions as there may be answer options that expand past the size of the window.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
February 5, 2021 ACMT/ASAM Addiction Toxicology Case Conference
Attend Live Webinar - Friday, February 5, 2021
This Live Component has been cancelled.
March 5, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session - March 5, 2021
Open to view video.
Open to view video. This video is approximately 60 minutes and was recorded on 03/05/2021.
View Presentation Slides - March 5, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
April 2, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session - April 2, 2021
Open to view video.
Open to view video. This video is approximately 60 minutes and was recorded on 04/02/2021.
View Presentation Slides - April 2, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
May 7, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session - May 7, 2021
Open to view video.
Open to view video. This video is approximately 60 minutes and was recorded on 05/07/2021.
View Presentation Slides - May 7, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
June 4, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session - June 4, 2021
Open to view video.
Open to view video. This video is approximately 60 minutes and was recorded on 06/04/2021.
View Presentation Slides - June 4, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
July 2, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session - July 2, 2021
Open to view video.
Open to view video. This video is approximately 60 minutes and was recorded on 07/02/2021
View Presentation Slides - July 2, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
August 6, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session- August 6, 2021
Open to view video.
Open to view video.
View Presentation Slides - August 6, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
September 3, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session- September 3, 2021
Open to view video.
Open to view video.
View Presentation Slides - September 3, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.
October 1, 2021 ACMT/ASAM Addiction Toxicology Case Conference
View On-Demand Session- October 1, 2021
Open to view video.
Open to view video.
View Presentation Slides - October 1, 2021
Open to download resource.
Open to download resource.
View Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available Beginning in January 2021, this session was not approved for credit. You can print a certificate of completion for your records.